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It is therefore important to produce more information about 
the use of medicinal plants based on the original sources. An 
example is the garden spurge, for which a study highlighting the 
importance of certain taxa to treat skin conditions in Brisbane, 
Australia allowed the identification and development of the sec-
ond most commonly mentioned species, Euphorbia peplus, as 
an interesting lead. It is now in Phase II clinical trials (Reuter 
et al., 2010). Additionally, when a source is used in a proper 
manner, it is a valid source of information. It is important to 
foster field-based ethnopharmacological studies as sources of 
new data, as highlighted by some authors (Edwards et al., 2005; 
Heinrich  et al., 2009).
The aim of this work is to provide LBBRs with a small set of 
analytical tools to select quantitative data from the field. These tools 
are designed to help researchers analyze the results of structured 
interviews of people who use the traditional medicine. To use these 
tools, the researchers do not necessarily need detailed training in 
social or cultural sciences.
Search Strategy
A search was performed in the following databases: Scopus1, Science 
Direct2, Web of Knowledge: Science Citation Index3, and Medline4. 
The keywords “ethnobotany,” “ethnopharmacology,” “index,” and 
IntroductIon
For ethnopharmacological experimental or clinical investigations, a 
relevant starting point is to understand who uses traditional medi-
cine and how researchers in one of the many areas of biomedicine 
can get useful information about this use, which can guide the 
selection of medicinal plants for more detailed study.
Ethnopharmacology was initially defined as “the interdisciplinary 
scientific exploration of biological active agents traditionally employed 
or observed by man” (Holmsted and Bruhn, 1983). Another definition 
was provided by Etkin and Elisabetsky (2005): “By one, compelling 
logic, ethno- (Gr., culture or people) pharmacology (Gr., drug) is about 
the intersection of medical ethnography and the biology of therapeutic 
action.” Based on the previous definitions, ethnopharmacology can be 
seen as the study of traditionally used, biologically active natural products, 
with the aim of understanding their therapeutic actions.
In ethnopharmacological experimental or clinical investigations, 
a crucial question is how the information about the use of natural 
products is obtained. One can expect that it comes directly from 
the people, who use the traditional medicine, important factor for 
non-written culture, in which the information is often passed down 
through oral communication. However, upon reviewing the ethnop-
harmacological literature describing local and traditional uses, one 
can see that the information does not always come directly from 
the people who use the remedy. Instead, the authors (lab-based-
biomedical-researchers, LBBRs), often obtain data from a secondary 
source, such as popular books, herbarium information, manufactur-
ers, or other sources who are not the primary users of the plants. A 
distortion of the original information about the remedy use may 
occur because the interpretation may differ from the primary source.
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The F
ic
 was calculated as the number of use citations in each 
category (N
ur
) minus the number of species used (Nt), divided by 
the number of use citations in each category minus one (Heinrich 
et al., 1998):
F
N Nt
Nic
ur
ur
=
−
−1
F
ic
 values range from 0.00 to 1.00. High F
ic
 values are obtained 
when only one or a few plant species are reported to be used by 
a high proportion of informants to treat a particular category, 
whereas low F
ic
 values indicate that informants disagree over 
which plant to use. As a result of this analysis, it was possible to 
identify species of particular importance within a culture (inter-
cultural) and to compare different cultures. Over the last 5 years 
this tool was used at least in 70 publications mainly to analyze 
the use of plant species in different ethnographic backgrounds; 
recent examples include Karousouand and Deirmentzoglou 
(2011) in Cyprus; Jacobo-Salcedo et al. (2011) in Mexico; 
Pandikumar et al. (2011) in India; Oliveira et al. (2010) in Brazil; 
Teklehaymanot and Giday (2009) in Ethiopia. F
ic
 has also been 
used to analyze the use of animal species (Ferreira et al., 2009 
and Upadhyay et al., 2010).
The main use of F
ic
 is to select disease categories where there is 
consensus on the use of plants among the informants and to identify 
species with particular importance in a culture.
FIdelIty level
Of equal importance is the fidelity level (Fl), initially proposed 
Friedman et al. (1986) to analyze plant use among Bedouins in 
Israel. Fl was defined as the ratio between the number of inform-
ants who independently suggested the use of a species for the same 
major purpose and the total number of informants who mentioned 
the plant for any use.
In the Fl, Np is the number of informants that reported a use 
of a plant species to treat a particular disease, and N is the number 
of informants that used the plants as a medicine to treat any given 
disease (Friedman et al., 1986);
Fl =
Np
N ×100
this index has been used in more than 50 manuscripts to identify 
the main use for one plant.
A limitation of this tool is that if a plant (A) has a low number 
of mentions (between two and three), the Fl can be high (100%); 
in contrast a plant (B) with more mentions (15 or more) may have 
a lower Fl (84%). This fact does not necessarily indicate more 
fidelity for plant (A) because in two uses there is 50% probability 
that the uses are different, whereas in 15 uses there is a greater 
probability of different uses and a low Fl (see Andrade-Cetto, 
2009). To avoid this problem, the use-mentions (UM) factor was 
proposed. The UM is defined as the number of mentions for one 
plant given by all of the informants for a specific disease. The 
resulting UM value can be then correlated with the Fl to identify 
a plant with high fidelity.
“consensus” were used independently or in combination and results 
from the last 5 years were analyzed. The common tools used in the 
manuscripts and other useful tools are presented and an interpreta-
tion on how these tools can be used together is given.
a revIew oF poSSIble approacheS
As part of the data collection, some general requirements are 
important. The researcher needs to be precise about plant loca-
tion (GPS), ethnographic background, sample size, and research 
design. It also needs to be decided if the focus of the research is 
on plant knowledge of healers, the general public, or people with 
a specific disease.
QuantItatIve ethnobotanIcal StudIeS
A very comprehensive and critical comparative analysis of cul-
tural importance indices was performed by Tardio and Pardo de 
Santayana (2008), but they did not assess the ethnopharmacological 
relevance of this information, as it relates to their use in prioritizing 
species for further biomedical research.
With the aim of providing clear explanations of methods in 
ethnobotany for use by the research community, Hoffman and 
Gallaher (2007) performed an Internet search using Google Scholar 
with the search terms “ethnobotany” and “use value.” They recorded 
12 specific methods and classified them into four categories; uses 
totaled or (researcher-tally), subjective allocation or (researcher-
score), informant consensusor (informant tally), and informant 
consensusor (informant score) for the selection of the categories 
they use the proposal of Kvist et al. (1995) who used “tally” for 
methods that indiscriminately count every use cited and “score” for 
methods that sort uses into pre-determined hierarchical categories. 
In this work, they define relative cultural importance (RCI) indi-
ces as “quantitative measures designed to transform the complex, 
multidimensional concept of ‘importance’ into standardized and 
comparable numerical scales or values.” They provide a set of 24 
different formulas that can be applied to select plants used by man 
with any purpose.
Factor oF InFormant conSenSuS
One of the most widely used tools is the factor of informant con-
sensus (F
ic
). Its current form, proposed by Heinrich et al. (1998), 
was based on a similar but not identical definition first introduced 
by Trotter and Logan (1986).
F
ic
 was used to identify plants of particular intercultural rel-
evance and to agree on their use. It was originally used to analyze 
three populations with culturally different backgrounds in Mexico.
To use F
ic
, it is necessary to classify illnesses into broad disease 
categories (several diseases based on the organ systems in one 
category). The original categories used by Heinrich et al. (1998) 
include conditions common to all five ethnic groups in Mexico: 
(1) gastrointestinal, (2) dermatological (mostly infections and sub-
sequent inflammatory reactions), (3) respiratory, and (4) gyne-
cological and andrological. They also compared illnesses deemed 
to be specific to one or two cultures such as “poisonous animal 
bites and stings” (Maya); ophthalmological illnesses (Maya and 
Zapotecs); and culture-bound syndromes (Nahua and Zapotecs). 
These authors used the formula.
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Whit the formula:
DCI=
Vxi
Cc
mVx Pm
=1i
∞
−∑

 0 1.
In the original work, the following questions were used to calculate 
the index: (1) species name; (2) general plant description; (3) mode 
of preparation; (4) form of administration during a treatment; (5) 
“organoleptic” characteristics, such as flavor, odor, and texture; (6) 
main symptoms after the consumption of the species; (7) how often 
the species (in tea form) must be administered; (8) whether the per-
son felt better after consuming the species; (9) general knowledge 
about the region of gathering or information about how to grow 
the species; (10) whether the patient recommended the species to 
other members of the community.
For the binary evaluation, only the alternatives “yes” or “no” 
are considered, not the main answer. For example, in Question 1, 
if the person knows the species name then the score for the index 
is one, no matter of what name s/he gives the species (thus, one 
species may have more than one vernacular names). Likewise, for 
Question 2 the score is 1 if the person describes the species in some 
detail. If they cannot describe it, the score is 0.
For the application of this methodology, some prerequisites are 
necessary: (1) the previous selection of the informants (normally 
those who present with the selected disease) and (2) the species 
need to be identified prior to the interviews.
This index is useful to select the plants most used by the inform-
ants (patients) to treat a single disease within a specific community.
SImple percentage
The simple percentage was employed by El-Hilal et al. (2003) in a 
study in a northern province of Morocco to highlight the relation-
ship between medicinal plants and main therapeutic indications 
selected according to interviews. The sum of all the indications was 
defined as 100%, and the percentage of each single indication was 
then calculated. This analysis is useful to select the main diseases 
in a study area.
relatIve Importance Index
In an effort to understand how species were introduced to the 
pharmacopeia of northern South America, Bennett and Prance 
(2000) proposed the RI index. Originally, they compiled data on 
medicinal plants from their own studies and from selected publica-
tions. The RI was then calculated for each medicinal plant based 
on the normalized number of body systems (BS) that one species 
affects and the pharmacological proprieties (PH) that are attributed 
to the same species. The result can have a maximum value of 2; the 
final value is multiplied by 50 to convert to a scale of 100.
For example, if a species X is employed to treat 12 BS, the maxi-
mum any species can obtain is a normalized value of BS of 12/12 = 1. 
If X has a pH value of 15 pH, while the most versatile species Y has 
a pH value of Y, then the normalized pH value of X is 15/17 = 1.88. 
To convert to a scale of 100, the combined values (1 + 1.88) are 
multiplied by 50, giving an RI of 2.88 × 50 = 94.1. The index was 
adapted by Albuquerque and Oliveira (2007) to test the hypothesis 
that the RI can be explained by the species habitat or its status 
(spontaneous or cultivated, endemic or not endemic) as follows:
uSe-value For one SpecIeS
The use-value (UV) index was used to calculate the citation of plants 
during interviews, proposed by Phillips and Gentry (1993a,b) and 
adapted by Albuquerque et al. (2007). It is calculated as follows:
UVc U ns= ∑ is /
where U is the sum of the total number of use citations by all 
informants for a given species, divided by the total number of 
informants (ns). This method evaluates the relative importance 
(RI) of each medicinal species based on its relative use among 
informants.
This index is useful for the analysis of the use of a single species 
and to compare plants among the same sample (for example, see 
Aburjai et al., 2007).
SpecIeS uSe-value For one InFormant
The species UV index was used to calculate the number of uses 
mentioned for species by one informant in different events (Phillips 
and Gentry, 1993a,b).
UV U Nis is is= ∑( ) ( )/
Where U
is
 is the number of uses mentioned for species s by the 
informant and N
is
 is the number of events in which the informant 
cites a use for species s.
This index is useful if a researcher goes into the field with one 
informant with the aim of collecting a specific species, but during 
the course of the field study, the informant mentions other plants; 
each time the informant stops and gives information about a spe-
cies is an “event.”
The expected score for each species is 1, which means that, if a 
species was found four times, the informant mentioned the species 
four times for the same use.
dISeaSe-conSenSuS Index
With the aim of selecting species to treat a single, usually chronic dis-
ease, Andrade-Cetto et al. (2006) developed the disease- consensus 
index (DCI). For the application of the index, it is necessary to 
formulate a questionnaire with answers that can be evaluated in 
a binary way: 0 for no and 1 for yes. The questions must include 
personal knowledge about a specific species to treat the disease (see 
below). The index is a comparison based on mathematical aspects 
(limit theory), the ideal answers of informant reports (Cc) and the 
ideal answers for each species (Vx).
It is calculated as follows: where;
• (x) is any species.
• (mVxi) is the sum of the individual values obtained for one 
species within the community; it evaluates knowledge and 
mentions.
• (mVx) is the statistical mean of the individual values for one 
species; it evaluates knowledge.
• Cc is the correlation coefficient, defined as the maximal num-
ber of informants who refer to a species; it evaluates mentions.
• Pm−0.1 is the compensation factor, and analyses the disper-
sion for one species, considering the mode of preparation and 
parts used.
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hand, that LBBRs, in general does not have an ethnological back-
ground and thus the subjective data interpretation can be a problem 
and on the other hand, reliable and repeatable data about the plants 
are needed for further pharmacological studies, we propose the use 
of quantitative analysis in field studies performed by LBBRs.
The factor of informant consensus is particularly useful to select 
the categories of diseases for which the species are traditionally 
used. By applying this tool, researchers can identify the main dis-
eases in a community grouped by category. In addition to F
ic
, Fl can 
be used to select single plants. This combination allows the selection 
of one or more species used in the main categories. These analyses 
can be completed using, simple percentage and UM.
The UV index allows the identification of a species within a 
sample without taking into account its use (Category); this is useful 
in the comparison between species for the whole sample. While the 
species UV is useful during field studies with a single informant, the 
score for one species can be compared between several informants.
If the objective of the analysis is to identify plants used to treat 
a specific chronic disease, then the DCI is the best option.
Finally, the RI index can help the researcher analyze previous 
field studies already reported in the literature.
With the goal of obtaining information about the traditional 
use of plants, the indices presented here provide a set of tools for 
the quantitative analysis of an ethnopharmacological field study.
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RI=NCS+NP, NCS=NCSS/NSCSV, NP=NPS/NPSV
where NCS is the number of BS, NCSS the number of BS treated by 
a given species, NSCSV the total number of BS treated by the most 
versatile species (the most versatile species are those that have the 
greatest number of medicinal properties), NP the number of phar-
macological properties, NPS the number of properties attributed 
to a species and NPSV the total number of properties attributed 
to the most versatile species.
The main use of this index is to measure the potential of a given 
medicinal species, including its capacity to treat more than one 
health problem. It has been used to analyze data presented previ-
ously in the literature.
dIScuSSIon
Over the last 5 years, more than 800 ethnobotanical studies have 
quantitatively analyzed data; nearly 90% of these studies are about 
medicinal plants.
The objective of a field-based study (the “ethno” in “ethnophar-
macology”) often is the selection of species for further pharma-
cological studies, but it should not be limited to this goal. While 
such field studies should be stand-alone contribution, from the 
perspective of an experimental pharmacologist or a phytochemist, 
a range of key outcomes of such field studies are desirable.
The analysis of the data obtained in these studies requires the inter-
pretation of the researcher. The main analysis regarding the traditional 
use of the species to treat a disease requires subjective interpretation 
and thus cannot be measured quantitatively. If we considered, in one 
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